These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22863636)

  • 1. Letter: Alopecia areata during ustekinumab administration: Co-existence or an adverse reaction?
    Verros C; Rallis E; Crowe M
    Dermatol Online J; 2012 Jul; 18(7):14. PubMed ID: 22863636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alopecia areata during anti-TNF alpha therapy: Nine cases].
    Le Bidre E; Chaby G; Martin L; Perrussel M; Sassolas B; Sigal ML; Kaassis C; Lespessailles E; Nseir A; Estève E
    Ann Dermatol Venereol; 2011; 138(4):285-93. PubMed ID: 21497255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ustekinumab and herpes zoster.
    Failla V; Nikkels AF
    Dermatology; 2011; 222(2):119-22. PubMed ID: 21266799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alopecia areata universalis elicited during treatment with adalimumab.
    Pelivani N; Hassan AS; Braathen LR; Hunger RE; Yawalkar N
    Dermatology; 2008; 216(4):320-3. PubMed ID: 18230980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
    Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
    J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rapid onset of multiple squamous cell carcinomas in two patients commenced on ustekinumab as treatment of psoriasis.
    Young L; Czarnecki D
    Australas J Dermatol; 2012 Feb; 53(1):57-60. PubMed ID: 22309334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
    Tosti A; Iorizzo M; Botta GL; Milani M
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Koebner phenomenon in alopecia areata: rapid appearance after trichogram. Implications for the pathogenesis and therapy.
    D'Ovidio R
    G Ital Dermatol Venereol; 2013 Apr; 148(2):225-9. PubMed ID: 23588149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors that affect the response to topical treatment in patchy alopecia areata.
    Ucak H; Cicek D; Demir B; Erden I; Ozturk S
    J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):34-40. PubMed ID: 23181708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based exposure-efficacy modeling of ustekinumab in patients with moderate to severe plaque psoriasis.
    Zhou H; Hu C; Zhu Y; Lu M; Liao S; Yeilding N; Davis HM
    J Clin Pharmacol; 2010 Mar; 50(3):257-67. PubMed ID: 19934030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy.
    Barahmani N; Lopez A; Babu D; Hernandez M; Donley SE; Duvic M
    Clin Exp Dermatol; 2010 Jun; 35(4):409-16. PubMed ID: 19874320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: a case and review of the literature.
    Navarro R; Daudén E; Gallo E; Santiago Sánchez-Mateos D; García-Diez A
    Skin Pharmacol Physiol; 2012; 25(2):107-10. PubMed ID: 22301842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia areata in children.
    Hawit F; Silverberg NB
    Cutis; 2008 Aug; 82(2):104-10. PubMed ID: 18792541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of alopecia areata: modern principles and perspectives].
    Brajac I; Kastelan M; Perisa D; Simonić E; Stojnić-Sosa L; Massari LP
    Lijec Vjesn; 2010; 132(11-12):365-9. PubMed ID: 21294327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia areata following adalimumab.
    Kirshen C; Kanigsberg N
    J Cutan Med Surg; 2009; 13(1):48-50. PubMed ID: 19298772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin: a new facilitating factor in alopecia areata pathogenesis?
    Ganzetti G; Simonetti O; Campanati A; Giuliodori K; Scocco V; Brugia M; Tocchini M; Offidani A
    Acta Dermatovenerol Croat; 2015; 23(1):19-22. PubMed ID: 25969908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alopecia areata developing during ustekinumab therapy: report of two cases.
    Tauber M; Beneton N; Reygagne P; Bachelez H; Viguier M
    Eur J Dermatol; 2013; 23(6):912-3. PubMed ID: 24334218
    [No Abstract]   [Full Text] [Related]  

  • 19. Alopecia areata update.
    Madani S; Shapiro J
    J Am Acad Dermatol; 2000 Apr; 42(4):549-66; quiz 567-70. PubMed ID: 10727299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases.
    de Souza A; Ali-Shaw T; Reddy SM; Fiorentino D; Strober BE
    Br J Dermatol; 2013 Jan; 168(1):210-2. PubMed ID: 23278559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.